Almanac 2013: cardiac arrhythmias and pacing (Q38125860)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on August 2013

Language	Label	Description	Also known as
English	Almanac 2013: cardiac arrhythmias and pacing	scientific article published on August 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Almanac 2013: cardiac arrhythmias and pacing (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

author name string

Reginald Liew

1

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

language of work or name

0 references

publication date

1 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

99

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

1398-1407

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: the Atherosclerosis Risk in Communities study

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Increased risk of atrial fibrillation in patients with coeliac disease: a nationwide cohort study

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

The impact of height on the risk of atrial fibrillation: the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Mild cognitive impairment in high-risk patients with chronic atrial fibrillation: a forgotten component of clinical management?

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Association of plasma phospholipid long-chain ω-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Atrial fibrillation and death after myocardial infarction: a community study

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Assessment of female sex as a risk factor in atrial fibrillation in Sweden: nationwide retrospective cohort study

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation).

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Lenient versus strict rate control in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

The effect of rate control on quality of life in patients with permanent atrial fibrillation: data from the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) study

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Effect of lenient versus strict rate control on cardiac remodeling in patients with atrial fibrillation data of the RACE II (RAte Control Efficacy in permanent atrial fibrillation II) study.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Prevention of atrial fibrillation with omega-3 fatty acids: a meta-analysis of randomised clinical trials

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Ambulatory external electrocardiographic monitoring: focus on atrial fibrillation

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

A comprehensive evaluation of rhythm monitoring strategies for the detection of atrial fibrillation recurrence: insights from 647 continuously monitored patients and implications for monitoring after therapeutic interventions

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Does additional linear ablation after circumferential pulmonary vein isolation improve clinical outcome in patients with paroxysmal atrial fibrillation? Prospective randomised study.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Associations between the atrial electromechanical interval, atrial remodelling and outcome of catheter ablation in paroxysmal atrial fibrillation

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Procedural complications, rehospitalizations, and repeat procedures after catheter ablation for atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Apixaban versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Efficacy and safety of the novel oral anticoagulants in atrial fibrillation: a systematic review and meta-analysis of the literature.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Dabigatran versus warfarin therapy for uninterrupted oral anticoagulation during atrial fibrillation ablation

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in UK patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Percutaneous atrial appendage occlusion for stroke prevention in patients with atrial fibrillation: a systematic review

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patien

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Importance of the underlying substrate in determining thrombus location in atrial fibrillation: implications for left atrial appendage closure

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Right ventricular function and survival following cardiac resynchronisation therapy

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Cardiac-resynchronization therapy for the prevention of heart-failure events

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Predictors of Response to Cardiac Resynchronization Therapy in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT)

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Cardiac resynchronization and quality of life in patients with minimally symptomatic heart failure

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Left ventricular lead position and clinical outcome in the multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT) trial

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Does ventricular dyssynchrony on echocardiography predict response to cardiac resynchronisation therapy? A randomised controlled study

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Cardiac resynchronisation therapy in patients with heart failure and a normal QRS duration: the RESPOND study.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Biventricular pacing is superior to right ventricular pacing in bradycardia patients with preserved systolic function: 2-year results of the PACE trial

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Long-term follow-up of older patients with Mobitz type I second degree atrioventricular block

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Adenosine plasma level and A2A adenosine receptor expression: correlation with laboratory tests in patients with neurally mediated syncope

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Treatment of unexplained syncope: a multicenter, randomized trial of cardiac pacing guided by adenosine 5'-triphosphate testing

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Syncope due to idiopathic paroxysmal atrioventricular block: long-term follow-up of a distinct form of atrioventricular block

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Prognosis among healthy individuals discharged with a primary diagnosis of syncope

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Long-term outcomes following infection of cardiac implantable electronic devices: a prospective matched cohort study

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Timing of the most recent device procedure influences the clinical outcome of lead-associated endocarditis results of the MEDIC (Multicenter Electrophysiologic Device Infection Cohort).

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Circumstances and outcomes of sudden unexpected death in patients with high-risk myocardial infarction: implications for prevention

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Electrocardiographic and clinical predictors separating atherosclerotic sudden cardiac death from incident coronary heart disease

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Sports-related sudden death in the general population.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Sudden Death in Young Adults

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Nationwide study of sudden cardiac death in persons aged 1-35 years

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Risk factors for sudden cardiac death in post-menopausal women

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Sudden cardiac arrest associated with early repolarization

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Long-term outcome associated with early repolarization on electrocardiography

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Prevalence of J-point elevation in sudden arrhythmic death syndrome families

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Identification of large families in early repolarization syndrome

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Early repolarisation: controversies and clinical implications

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Clinical significance of variants of J-points and J-waves: early repolarization patterns and risk

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Sudden death and ion channel disease: pathophysiology and implications for management

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Genetics and cardiovascular disease--causes and prevention of unexpected sudden adult death: the role of the SADS clinic.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Molecular biology and clinical management of arrhythmogenic right ventricular cardiomyopathy/dysplasia.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Non-cardiovascular drugs that inhibit hERG-encoded potassium channels and risk of sudden cardiac death

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES risk score

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Implantable Cardioverter-Defibrillator Registry Risk Score Models for Acute Procedural Complications or Death After Implantable Cardioverter-Defibrillator Implantation

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Scar size and characteristics assessed by CMR predict ventricular arrhythmias in ischaemic cardiomyopathy: comparison of previously validated models

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Assessment of myocardial scarring improves risk stratification in patients evaluated for cardiac defibrillator implantation

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Intracardiac electrogram T-wave alternans/variability increases before spontaneous ventricular tachyarrhythmias in implantable cardioverter-defibrillator patients: a prospective, multi-center study

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Impact of continuous intracardiac ST-segment monitoring on mid-term outcomes of ICD-implanted patients with coronary artery disease. Early results of a prospective comparison with conventional ICD outcomes.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Longevity of Sprint Fidelis implantable cardioverter-defibrillator leads and risk factors for failure: implications for patient management

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Clinical predictors of Fidelis lead failure: report from the Canadian Heart Rhythm Society Device Committee.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Sprint Fidelis lead fractures in patients with cardiac resynchronization therapy devices: insight from the Resynchronization/Defibrillation for Ambulatory Heart Failure (RAFT) study

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Determinants and trajectory of phobic anxiety in patients living with an implantable cardioverter defibrillator

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Long-term complications related to biventricular defibrillator implantation: rate of surgical revisions and impact on survival: insights from the Italian Clinical Service Database

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Preventing Overdiagnosis of Implantable Cardioverter-Defibrillator Lead Fractures Using Device Diagnostics

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults: cause for caution

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Infrequent physician use of implantable cardioverter-defibrillators risks patient safety

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

The clinical management of relatives of young sudden unexplained death victims; implantable defibrillators are rarely indicated

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Out-of-hospital cardiac arrest: recent advances in resuscitation and effects on outcome.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Advances in the hospital management of patients following an out of hospital cardiac arrest.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Increases in survival from out-of-hospital cardiac arrest: a five year study

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Increase in survival and bystander CPR in out-of-hospital shockable arrhythmia: bystander CPR and female gender are predictors of improved outcome. Experiences from Sweden in an 18-year perspective.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Ventricular tachyarrhythmias after cardiac arrest in public versus at home

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Incidence, causes, and outcomes of out-of-hospital cardiac arrest in children. A comprehensive, prospective, population-based study in the Netherlands

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Chest compressions before defibrillation for out-of-hospital cardiac arrest: a meta-analysis of randomized controlled clinical trials.

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Conventional and chest-compression-only cardiopulmonary resuscitation by bystanders for children who have out-of-hospital cardiac arrests: a prospective, nationwide, population-based cohort study

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Outcomes of chest compression only CPR versus conventional CPR conducted by lay people in patients with out of hospital cardiopulmonary arrest witnessed by bystanders: nationwide population based observational study

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Pericardial Fat Is Associated With Atrial Fibrillation Severity and Ablation Outcome

1 reference

https://api.crossref.org/works/10.1136%2FHEARTJNL-2013-304592

21 January 2018

Identifiers

10.1136/HEARTJNL-2013-304592

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38125860&oldid=1742977863"